Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.666,95
-0,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Harpoon Therapeutics Inc (HARP) Harpoon Therapeutics Inc (HARP) Notizie

Harpoon Therapeutics Inc

HARP
23,01
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202414:55EDGAR2Form POS AM - Post-Effective amendments for registration..
11/3/202414:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/3/202413:47EDGAR2Form 8-K - Current report
08/3/202422:04EDGAR2Form 8-K - Current report
28/2/202413:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/2/202413:34EDGAR2Form 8-K - Current report
22/2/202414:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/2/202414:31EDGAR2Form 8-K - Current report
08/2/202413:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
06/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202422:52EDGAR2Form PREM14A - Preliminary proxy statements relating to..
29/1/202422:28EDGAR2Form 8-K - Current report
10/1/202421:07PRNUSKuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to..
09/1/202412:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
08/1/202423:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/1/202423:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/1/202414:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/1/202414:01EDGAR2Form 8-K - Current report
08/1/202413:30BWMerck to Acquire Harpoon Therapeutics, Further Diversifying..
05/1/202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/12/202313:30GLOBEHarpoon Therapeutics Strengthens Leadership Team
22/12/202322:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
19/12/202313:30GLOBEHarpoon Therapeutics Abstract for HPN328 Accepted for Rapid..
12/12/202302:15GLOBEHarpoon Therapeutics Presents HPN217 Phase 1 Clinical Data..
08/12/202322:08EDGAR2Form S-3 - Registration statement under Securities Act of..
28/11/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:14EDGAR2Form 8-K - Current report
24/11/202320:06EDGAR2Form 8-K - Current report
24/11/202320:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/11/202322:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:11EDGAR2Form 8-K - Current report
09/11/202322:01GLOBEHarpoon Therapeutics Reports Third Quarter 2023 Financial..
03/11/202321:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202314:15GLOBEHarpoon Therapeutics Abstract for HPN217 Accepted for..
26/10/202323:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
23/10/202314:00EDGAR2Form 8-K - Current report
23/10/202313:17GLOBEHarpoon Therapeutics Announces Up to $150 Million Private..
21/10/202317:31GLOBEHarpoon Therapeutics Announces Updated Interim Tolerability..
16/10/202322:05GLOBEHarpoon Therapeutics to Host Webcast Reviewing HPN328..
09/10/202322:17GLOBEHarpoon Therapeutics to Present Interim Tolerability and..
02/10/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202309:00GLOBEHarpoon Therapeutics Presents HPN217 Interim Phase 1 Data at..
15/9/202313:15GLOBEHarpoon Therapeutics Announces First Patients with Small..
13/9/202323:12DJNHarpoon Shares Drop 7.3% as AbbVie Declines License Option
13/9/202322:55DJNHarpoon Therapeutics Says AbbVie Declines to Exercise..
13/9/202322:15EDGAR2Form 8-K - Current report
13/9/202322:05GLOBEHarpoon Therapeutics Provides an Update on the HPN217..
06/9/202313:30GLOBEHarpoon Therapeutics Abstract for HPN217 Accepted for Poster..
Apertura: Min: Max:
Chiusura: 23,01

La tua Cronologia

NASDAQ
HARP
Harpoon Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network